Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: A report of the Late Effects Surveillance System (LESS)

M. Paulides, A. Kremers, W. Stöhr, S. Bielack, H. Jürgens, J. Treuner, J. D. Beck, T. Langer*

*Corresponding author for this work
53 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: A report of the Late Effects Surveillance System (LESS)'. Together they form a unique fingerprint.

Medicine & Life Sciences